An Open Trial to Evaluate the Efficacy and Safety of Infliximab(Remicade) in Treating Patients With Early Ankylosing Spondylitis.
Phase of Trial: Phase IV
Latest Information Update: 03 Feb 2016
At a glance
- Drugs Infliximab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 18 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jul 2009 New trial record